Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation in Patients Under 60 Years of Age

Overview

About this study

The purpose of this study is to evaluate the outcomes of RTSA versus ORIF in patients 60 years and younger who present with acute PHF, determined via postoperative range of motion (ROM), Single Assessment Numeric Evaluation score (SANE), American Shoulder and Elbow Surgeons score (ASES), and numerical pain rating scale (NPRS). Our aim is to determine whether RTSA and/or ORIF are effective in patients under 60 with proximal humerus fractures through evaluation of these outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18 or older with proximal humerus fracture who were treated with open reduction internal fixation (ORIF) or reverse total shoulder arthroplasty (RTSA)

Exclusion Criteria:

Patients who underwent delayed operative management of PHF (> 4 weeks after injury), patients who were treated with RTSA after failing ORIF, patients who did not undergo surgical intervention, patients who can‘t be reached or do not return questionnaires, or patients who are incarcerated or deceased.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/15/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Jennifer Tangtiphaiboontana, M.D.	Open for enrollment	Contact information: Megan Anderson (507) 293-1322 Anderson.Megan6@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jennifer Tangtiphaiboontana, M.D.

Open for enrollment

Contact information:

Megan Anderson

(507) 293-1322

Anderson.Megan6@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials